These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 19262053)
1. [Case of primary malignant lymphoma of the liver treated by R-CHOP therapy]. Asagi A; Miyake Y; Ando M; Yasuhara H; Matsumoto K; Takahara M; Kawai D; Kaji E; Toyokawa T; Onishi T; Miyatani K; Nakatsu M Nihon Shokakibyo Gakkai Zasshi; 2009 Mar; 106(3):389-96. PubMed ID: 19262053 [TBL] [Abstract][Full Text] [Related]
2. [A case of primary hepato-biliary malignant lymphoma effectively treated with R-CHOP chemotherapy]. Hiramoto K; Kuroki M; Shoji H; Matsumura Y; Miura A; Kikuchi Y; Hirakawa H; Kimura J; Matsuda M Gan To Kagaku Ryoho; 2010 Jul; 37(7):1345-8. PubMed ID: 20647724 [TBL] [Abstract][Full Text] [Related]
3. The successful treatment of primary cardiac lymphoma with a dose-dense schedule of rituximab plus CHOP. Dawson MA; Mariani J; Taylor A; Koulouris G; Avery S Ann Oncol; 2006 Jan; 17(1):176-7. PubMed ID: 16157624 [No Abstract] [Full Text] [Related]
4. [Case of malignant lymphoma arising from the posterior mediastinum, with pleural effusion]. Nagashima O; Takahashi K; Sato K; Suzuki T; Fukuchi Y; Isobe Y; Oshimi K Nihon Kokyuki Gakkai Zasshi; 2004 Aug; 42(8):772-6. PubMed ID: 15455953 [TBL] [Abstract][Full Text] [Related]
5. Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era. Avivi I; Zilberlicht A; Dann EJ; Leiba R; Faibish T; Rowe JM; Bar-Shalom R Am J Hematol; 2013 May; 88(5):400-5. PubMed ID: 23423884 [TBL] [Abstract][Full Text] [Related]
6. [Primary hepatic lymphoma - favorable outcome with chemotherapy plus rituximab]. Serrano-Navarro I; Rodríguez-López JF; Navas-Espejo R; Pérez-Jacoiste MA; Martínez-González MA; Grande C; Prieto S Rev Esp Enferm Dig; 2008 Nov; 100(11):724-8. PubMed ID: 19159179 [TBL] [Abstract][Full Text] [Related]
7. R-CHOP-14 in patients with diffuse large B-cell lymphoma: feasibility and preliminary efficacy. Halaas JL; Moskowitz CH; Horwitz S; Portlock C; Noy A; Straus D; O'Connor OA; Yahalom J; Zelenetz AD Leuk Lymphoma; 2005 Apr; 46(4):541-7. PubMed ID: 16019482 [TBL] [Abstract][Full Text] [Related]
8. [Comparison between R-CHOP regimen and CHOP regimen in treating naive diffuse large B-cell lymphoma in China--a multi-center randomized trail]. Lin TY; Zhang HY; Huang Y; Guan ZZ; Shen T; Shi YK; Zhu J; Ke XY; Wang HQ; Shen ZX; Yu SY; Liu T; Shi XL Ai Zheng; 2005 Dec; 24(12):1421-6. PubMed ID: 16351785 [TBL] [Abstract][Full Text] [Related]
9. [The efficacy and adverse effects of rituximab with CHOP or THP-COP in old-old and extremely old patients with diffuse large B cell lymphoma]. Kikukawa M; Miyazaki K; Kiuchi A; Abe S; Fujii H; Kanaya K; Shin K; Iwamoto T Nihon Ronen Igakkai Zasshi; 2006 Mar; 43(2):236-40. PubMed ID: 16683659 [TBL] [Abstract][Full Text] [Related]
10. [A case of pulmonary intravascular lymphoma treated with CHOP chemotherapy plus rituximab]. Ohkubo H; Yoshida T; Ohta K; Takaku T; Katagiri T; Paku J; Kasuga I; Minemura K; Gotoh A; Serizawa H; Mukai K; Ohyashiki K Gan To Kagaku Ryoho; 2005 Apr; 32(4):553-6. PubMed ID: 15853227 [TBL] [Abstract][Full Text] [Related]
11. [Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma]. Wu HJ; Zhang QY; Chen DF; Guan XJ; Zhang BL; Ma J Ai Zheng; 2005 Dec; 24(12):1498-502. PubMed ID: 16351800 [TBL] [Abstract][Full Text] [Related]
12. [A case of primary hepatic lymphoma successfully treated by THP-COP therapy]. Takauchi K; Kono H; Ito T; Zaima K; Okumoto S Nihon Ronen Igakkai Zasshi; 2003 Jan; 40(1):65-8. PubMed ID: 12649851 [TBL] [Abstract][Full Text] [Related]
13. [A case of primary pulmonary malignant lymphoma associated with autoimmune hemolytic anemia]. Kubota Y Nihon Kokyuki Gakkai Zasshi; 2006 Jun; 44(6):453-7. PubMed ID: 16841717 [TBL] [Abstract][Full Text] [Related]
14. FcgammaRIIB expression in diffuse large B-cell lymphomas does not alter the response to CHOP+rituximab (R-CHOP). Camilleri-Broët S; Mounier N; Delmer A; Brière J; Casasnovas O; Cassard L; Gaulard P; Christian B; Coiffier B; Sautès-Fridman C Leukemia; 2004 Dec; 18(12):2038-40. PubMed ID: 15470484 [No Abstract] [Full Text] [Related]
15. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles. Cunningham D; Hawkes EA; Jack A; Qian W; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford JA; McMillan A; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D Lancet; 2013 May; 381(9880):1817-26. PubMed ID: 23615461 [TBL] [Abstract][Full Text] [Related]
16. [Case of malignant lymphoma of the prostate complicated with prostate adenocarcinoma]. Chin K; Fujimura M; Sekit N; Mikami K; Kamijima S; Suzuki H; Ichikawa T Nihon Hinyokika Gakkai Zasshi; 2009 Nov; 100(7):698-702. PubMed ID: 19999135 [TBL] [Abstract][Full Text] [Related]
17. Successfully-treated mesenteric non-Hodgkin's lymphoma involving hepatic mass--a case report. Yamaguchi T; Takahashi H; Kagawa R; Takeda R; Sakata S; Yamamoto M; Nishizaki D; Takamatsu T; Iwasa Y Gan To Kagaku Ryoho; 2007 May; 34(5):783-7. PubMed ID: 17496458 [TBL] [Abstract][Full Text] [Related]
18. Successful treatment of primary cardiac lymphoma by rituximab-CHOP and high-dose chemotherapy with autologous peripheral blood stem cell transplantation. Nonami A; Takenaka K; Kamezaki K; Miyamoto T; Harada N; Nagafuji K; Teshima T; Harada M Int J Hematol; 2007 Apr; 85(3):264-6. PubMed ID: 17483065 [TBL] [Abstract][Full Text] [Related]
19. Sustained remission after rituximab-containing chemotherapy for intravascular large B-cell lymphoma. Shimada K; Kosugi H; Narimatsu H; Shimada S; Suzuki T; Ito M; Kinoshita T; Mori N; Naoe T J Clin Exp Hematop; 2008 Apr; 48(1):25-8. PubMed ID: 18434690 [TBL] [Abstract][Full Text] [Related]
20. [Application of 18F-FDG PET for the assessment of early response to the treatment and prognosis of patients]. Oriuchi N; Higuchi T; Endo K; Tsukamoto N; Matsuda H; Kuji I; Murakami K; Nakajima K Kaku Igaku; 2009 Jun; 46(2):96-9. PubMed ID: 19637820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]